How to read a package leaflet: What the patient does not understand and you can explain

What it is

The package leaflet is the technical and legal document that comes with every medicine. It is written to meet regulatory requirements, not for the patient to understand.

Many patients do not properly understand the leaflet's instructions. Your role at the counter is to translate that technical language into useful, personalised instructions.

The sections of the leaflet that matter most

In Spain the package leaflet has a fixed structure (Royal Decree 1345/2007):

Section 1 – What it is and what it is used for: the approved indications
Section 2 – What you need to know before: key contraindications and interactions
Section 3 – How to take it: dose, how to take it, what to do if a dose is missed
Section 4 – Possible side effects: from very common (more than 1 in 10) to very rare (fewer than 1 in 10,000)
Section 5 – Storage: temperature, light, how long it lasts once opened

At the counter

When to recommend it

When the patient asks 'when do I take it' or 'what do I take it with'
To explain common side effects that can alarm but are to be expected
To clarify the difference between an absolute contraindication and a precaution
To explain the in-use period of eye drops, creams or syrups once opened

When not to

Do not use the leaflet as the only source: it may be out of date
Do not read the list of side effects out to the patient word for word: it creates unnecessary anxiety

What to say at the counter. The most useful line at the counter: 'The side effects in the leaflet include everything that has been seen in any patient during the trials. "Very common" ones affect more than 1 in 10 people, and "common" ones between 1 in 100 and 1 in 10. The rest are much rarer than the list makes them look.'

Warnings

Caution The leaflets of generic medicines can differ in minor details from the original, even when the active substance is the same.
Caution The interactions section is not exhaustive. For complex interactions, always use the summary of product characteristics or an up-to-date professional database.
Caution The in-use period after opening is not always visible: eye drops (4 weeks), insulins (4–6 weeks out of the fridge), children's syrups (it varies).
Caution 'May cause drowsiness and affect driving' matters especially for professional drivers, who sometimes do not read it.

What the leaflet does not make clear

The dose is usually given in mg or units, but it rarely explains body weight. Many children's medicines are dosed by weight in kg, not by age.
'Take with food' can mean very different things: with a meal (for absorption), after it (for stomach tolerance) or apart from it (so as not to interfere with absorption).
The interactions in the leaflet are those known at the time of authorisation. They are not exhaustive: always check against up-to-date databases.
The expiry date applies to the unopened pack. Many medicines (eye drops, syrups, creams) have a much shorter in-use period once opened, and it is not always clearly shown.

Package leaflet vs summary of product characteristics

Aspect	Package leaflet	Summary of product characteristics
Written for	Patient / user	Healthcare professional
Language	Simplified (in theory)	Technical and complete
Content	A summary for safe use	Complete pharmacological information
Where to find it	Inside the pack	CIMA (the Spanish medicines agency, AEMPS)
When to use it	Basic instructions for the patient	Technical professional queries

To resolve complex questions at the counter, the summary of product characteristics in CIMA (AEMPS) is the most up-to-date and reliable source in Spain.

Self-assessment

Three questions. When you check your answers you will see the explanation for each one.

A patient asks why the leaflet lists 'may cause death' as a rare side effect. How do you explain it? That this section is only a legal formality and does not really matter That the medicine is dangerous and perhaps they should see their doctor That 'rare' side effects affect fewer than 1 in 1,000 patients, and 'very rare' ones fewer than 1 in 10,000
A bottle of eye drops was opened 6 weeks ago. The patient asks whether they can keep using it because the expiry date says '12/2026'. What do you tell them? That they should keep it in the fridge so it lasts longer That once opened, eye drops have their own in-use period (usually 4 weeks, unless the leaflet says otherwise), even if the pack expiry date is later That they can use it until the date on the pack
What is the most reliable and up-to-date source for a summary of product characteristics in Spain? The medicine's package leaflet CIMA (the medicines information centre of the AEMPS) Wikipedia or general search engines

Training content. It does not replace the summary of product characteristics or clinical judgement.

← All pills